Unveiling Teleflex (TFX) Q4 Outlook: Wall Street Estimates for Key Metrics

Core Viewpoint - Teleflex (TFX) is expected to report quarterly earnings of $3.73 per share, reflecting a year-over-year decline of 4.1%, while revenues are anticipated to reach $925.96 million, marking a 16.4% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised down by 0.2% in the last 30 days, indicating a reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Estimates - The consensus estimate for 'Net Revenues- Interventional' is $274.02 million, showing a significant year-over-year increase of 70.8% [5]. - 'Net Revenues- Interventional Urology' is expected to be $80.73 million, reflecting a decline of 4.9% from the previous year [5]. - 'Net Revenues- OEM' is projected at $85.31 million, indicating a slight decrease of 0.1% year-over-year [5]. - 'Net Revenues- Vascular Access' is estimated to reach $205.12 million, with an increase of 8.4% from the prior year [6]. - 'Net Revenues- Anesthesia' is expected to be $99.90 million, reflecting a 4.8% increase year-over-year [6]. - 'Net Revenues- Other' is projected at $64.41 million, indicating a 10.7% increase from the previous year [6]. - 'Net Revenues- Surgical' is estimated at $128.49 million, showing a 5.4% increase year-over-year [7]. - 'Geographic Revenues- Americas' is expected to reach $577.44 million, reflecting a 6.8% increase from the prior year [7]. - 'Geographic Revenues- EMEA' is projected at $203.23 million, indicating a significant increase of 26.2% year-over-year [7]. - 'Geographic Revenues- Asia' is estimated to be $115.99 million, reflecting a 23.9% increase from the previous year [8]. Stock Performance - Teleflex shares have returned +7.3% over the past month, outperforming the Zacks S&P 500 composite, which has seen a -0.3% change [8]. - The company holds a Zacks Rank 4 (Sell), suggesting it may underperform the overall market in the near future [8].